Fig. 4.
Treatment outcomes of opportunistic infection among HTLV-1 carriers and ATL patients.
We investigated treatment outcomes of 12 cases of opportunistic infection among ATL patients and HTLV-1 carriers. The prognosis was poor: OS of 28 days and OS rate of 50% (6/12). Among 6 survivors, 5 presented with ATL PD (3 patients) and relapse of ATL (2 patients) at a median of 194 days (range 133–226). Thus, the median OS was 121 days and OS rate was 16.7% (2/12).